Rotate to portrait

Vizual Stocks works best vertically on mobile.

VizualStocks API
PUBLIC DATA DEFINITIONS

ImmunityBio KPI & segment coverage

Operating KPI and segment definitions available for ImmunityBio (IBRX) through the VizualStocks API.

IBRX5 metric seriesCatalog checked 2026-10-28
Metric catalog API reference Open in the interactive demo

Active metrics 5

SEGMENT

Anktiva Net Product Revenue

Net revenue from commercial sales of ANKTIVA, stored in base USD. Use the named product disclosure or product revenue, net row only while ANKTIVA is the sole commercial product; exclude Other revenues and total consolidated revenue. This is a product revenue component, not an operating reportable segment.

anktivaNetProductRevenue
Frequency
quarterly / annual
Reported history
Q2'24 — Q2'26
History endpoint
COMPANY KPI

Anktiva Unit Sales Volume

Issuer-reported annual ANKTIVA unit sales volume. Units are commercial units sold, not patients, doses administered, prescriptions or clinical participants. Do not derive units from growth percentages or prices.

anktivaUnitSalesVolume
Frequency
annual
Reported history
2025 — 2025
History endpoint
SEGMENT

Europe Revenue

Revenue attributed to Europe in the issuer geographic-revenue note, stored in base USD. Do not infer this from other revenue or drug authorization counts.

europeRevenue
Frequency
quarterly / annual
Reported history
Q1'26 — Q2'26
History endpoint
SEGMENT

Other Revenue

Reported other revenue, excluding ANKTIVA net product revenue, stored in base USD. Together with ANKTIVA net product revenue this reconciles to consolidated revenue.

otherRevenue
Frequency
quarterly / annual
Reported history
Q2'24 — Q2'26
History endpoint
SEGMENT

United States Revenue

Revenue attributed to the United States in the issuer geographic-revenue note, stored in base USD. Includes all revenue types; do not equate this with ANKTIVA product sales.

unitedStatesRevenue
Frequency
quarterly / annual
Reported history
Q1'26 — Q2'26
History endpoint